MicroRNA expression profiling: A molecular tool for defining the phenotype of hepatocellular tumors

Two recent conceptual advances have led to an exciting renaissance in genetic regulation of biological processes involved in cell growth, development, and function. The first was the recognition that many portions of the human genome that do not encode conventional protein‐coding genes can encode biologically active RNA species. The second was the identification of mechanisms by which small RNA molecules could regulate gene and protein expression. Consequently, there has been an increasing recognition of the role of genetically encoded regulatory RNA molecules in biological processes. These advances have resulted in several new hypotheses on the mechanistic role of noncoding RNA in physiological processes, and their deregulation in disease. In turn, these hypotheses are beginning to provide new insights into disease classifications and pathogenesis.

[1]  Laura Pelletier,et al.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.

[2]  P. Park,et al.  Mechanisms for the anti‐inflammatory effects of adiponectin in macrophages , 2008, Journal of gastroenterology and hepatology.

[3]  Krista A. Zanetti,et al.  Identification of metastasis‐related microRNAs in hepatocellular carcinoma , 2008, Hepatology.

[4]  Thomas D. Schmittgen,et al.  Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.

[5]  Peter Schirmacher,et al.  MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma , 2007, Hepatology.

[6]  Xiao-fang Yu,et al.  Microarray analysis of microRNA expression in hepatocellular carcinoma and non‐tumorous tissues without viral hepatitis , 2007, Journal of gastroenterology and hepatology.

[7]  Tsung-Cheng Chang,et al.  Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.

[8]  E. Olson,et al.  An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133 , 2007, Proceedings of the National Academy of Sciences.

[9]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[10]  C. Croce,et al.  Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. , 2007, Cancer research.

[11]  O. Kovalchuk,et al.  Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. , 2007, Mutation research.

[12]  K. Morimura,et al.  Peroxisome Proliferator-Activated Receptor α Regulates a MicroRNA-Mediated Signaling Cascade Responsible for Hepatocellular Proliferation , 2007, Molecular and Cellular Biology.

[13]  T. Patel,et al.  The MicroRNA let-7a Modulates Interleukin-6-dependent STAT-3 Survival Signaling in Malignant Human Cholangiocytes* , 2007, Journal of Biological Chemistry.

[14]  K. Ghoshal,et al.  Downregulation of miR‐122 in the rodent and human hepatocellular carcinomas , 2006, Journal of cellular biochemistry.

[15]  Tushar Patel,et al.  Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.

[16]  T. Okanoue,et al.  Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.

[17]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[18]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.